Monitoring and Managing Glucose Levels in People With Pancreatic Cancer
Conditions: Pancreatic Cancer; PDAC - Pancreatic Ductal Adenocarcinoma; Hyperglycemia Interventions: Procedure: Endocrinologist-directed target blood glucose level 4-10 mmol/L using data from a continuous glucose monitor (CGM); Other: Standard Care Sponsors: British Columbia Cancer Agency; University of British Columbia Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Endocrinology | Pancreas | Pancreatic Cancer | Research